Immune cell therapy takes on untreatable liver cancer
NCT ID NCT07713290
First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time
Summary
This study tests an experimental treatment called GKL-006, made from a person's own immune cells (iNKT cells), for liver cancer that cannot be surgically removed. Participants receive GKL-006 injections along with a standard procedure that blocks the tumor's blood supply (TACE). The main goal is to check safety and tolerability, with early looks at whether the cancer shrinks or progression slows.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- an experimental iNKT cell therapy called GKL-006, given by injection, combined with a standard liver cancer procedure called transarterial chemoembolization (TACE)
- What this could lead to
- If this works, it could offer a new treatment option for people with liver cancer that cannot be removed by surgery.
- What could go wrong
- This is a very early, small study (6 people) focused mainly on safety. The treatment may not shrink tumors or improve survival, and cell therapies can cause serious side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Ditan Hospital, Capital Medical University
Beijing, Beijing Municipality, 100015, China
-
Beijing You An Hospital
Beijing, Beijing Municipality, 100069, China
-
First Hospital of Shanxi Medical University
Taiyuan, Shanxi, 030001, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a triple therapy shrink untreatable liver tumors?
- Breath of life: new test could sniff out gut cancers before they spread
- Could your own immune cells keep liver cancer from coming back?
- New ultrasound technique could reveal hidden blood vessels in liver tumors
- New imaging tracer could spot hidden cancers and fibrosis in one scan
- Blood type no barrier? study tests liver transplant success across ABO barriers